Intermittent Cold-Blood Cardioplegia and Its Impact on Myocardial Acidosis during Coronary Bypass Surgery

Abstract

Background The purpose of the study was to assess the degree of myocardial acidosis in patients undergoing elective coronary bypass surgery, in whom intermittent cold-blood cardioplegia (ICBC) was used for myocardial protection. The results of this study are presented in comparison to those of a previous trial conducted by the same investigators, using a similar methodology, but with intermittent warm-blood cardioplegia (IWBC).

Patients and Methods In 15 patients undergoing elective myocardial revascularization with ICBC for myocardial protection, metabolic changes of global ischemia indicators, lactate and pH values (measured simultaneously in coronary sinus and arterial blood) were analyzed. Lactate concentrations and pH values were measured at the beginning and the end of each cardioplegia administration, and the change-overtime analysis of the values was performed. For comparison with the results of the previous study (IWBC method) consisting of 12 patients, the analysis of variance with repeated measurements, including tests for a crossover, group, and time effect were used.

Results Using the ICBC method, as compared with IWBC, no significant difference in the lactate production was observed during the first two successive cardioplegia administrations. During the third and fourth administrations, especially at the end of reperfusions, ICBC patients had a significantly lower lactate release and higher pH values, as compared with IWBC patients.

Conclusion Our results suggest that ICBC has an inhibiting effect on potentially progressive myocardial acidosis during cross-clamp period.

Keywords

myocardial protection - myocardial acidosis - coronary bypass surgery

• References

• 1 Calafiore AM, Teodori G, Mezzetti A , et al. Intermittent antegrade warm blood cardioplegia. Ann Thorac Surg 1995; 59 (2) 398-402
• 2 Graffigna AC, Nollo G, Pederzolli C, Ferrari P, Widesott L, Antolini R. Continuous monitoring of myocardial acid-base status during intermittent warm blood cardioplegia. Eur J Cardiothorac Surg 2002; 21 (6) 995-1001
• 3 Kubasiak LA, Hernandez OM, Bishopric NH, Webster KA. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc Natl Acad Sci U S A 2002; 99 (20) 12825-12830
• 4 Webster KA, Discher DJ, Kaiser S, Hernandez O, Sato B, Bishopric NH. Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. J Clin Invest 1999; 104 (3) 239-252
• 5 Karwatowska-Prokopczuk E, Nordberg JA, Li HL, Engler RL, Gottlieb RA. Effect of vacuolar proton ATPase on pHi, Ca2+, and apoptosis in neonatal cardiomyocytes during metabolic inhibition/recovery. Circ Res 1998; 82 (11) 1139-1144
• 6 Søraas CL, Friis C, Engebretsen KVT, Sandvik L, Kjeldsen SE, Tønnessen T. Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery. Am Heart J 2012; 164 (5) 779-785
• 7 Nesher N, Alghamdi AA, Singh SK , et al. Troponin after cardiac surgery: a predictor or a phenomenon?. Ann Thorac Surg 2008; 85 (4) 1348-1354
• 8 Borowski A, Kurt M, Calvo S , et al. Metabolic monitoring of postischemic myocardium during intermittent warm-blood cardioplegic administration. Tex Heart Inst J 2010; 37 (2) 184-188
• 9 Ranucci M, De Toffol B, Isgrò G, Romitti F, Conti D, Vicentini M. Hyperlactatemia during cardiopulmonary bypass: determinants and impact on postoperative outcome. Crit Care 2006; 10 (6) R167
• 10 Bical OM, Fromes Y, Paumier D, Gaillard D, Foiret JC, Trivin F. Does warm antegrade intermittent blood cardioplegia really protect the heart during coronary surgery?. Cardiovasc Surg 2001; 9 (2) 188-193
• 11 Nollo G, Ferrari P, Graffigna AC. Cold intermittent cardioplegia reduces the acidosis during prolonged cardiac surgery with cardiopulmonary bypass. Conf Proc IEEE Eng Med Biol Soc 2011; 2011: 8432-8435